Search Results

Juan José Fung is a Principal Scientist at GPCR Therapeutics, Inc , a drug discovery company focused Brian Kobilka , studying the dimerization of GPCRs. Dr. Juan José Fung on the web LinkedIn GPCR Therapeutics Dr. GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses GPCR Podcast? Leave a Review.

Pina Cardarelli, CSO for GPCR Therapeutics Inc., based in South Korea, has recently been named President of GPCR Therapeutics, USA, a newly incorporated Biotechnology company in the Bay Area. The company’s mission is to discover and develop highly effective cancer therapeutics by targeting heteromers She was an integral contributor to two therapeutics that are FDA approved, Yervoy and Opdivo. patents including anti-PD-1 patents, 22 EP patents, and greater than 100 global patents centered around therapeutic

Whether a 20% reduction in beta-arrestin coupling matters therapeutically depends on the cell type, the drug response differences, and a largely unexplored opportunity in existing drug pipelines Antibody therapeutics Antibody therapeutics for GPCRs: the pipeline argument Biologics have a substantially higher success The combination of those two facts, Gilchrist argues, makes antibody-based GPCR therapeutics an underexplored The precedent of drugging a receptor without knowing what activates it naturally, and getting therapeutic

Your One-Stop-Shop for GPCR Drug Discovery and Development Researchers developing GPCR-targeted therapeutics solutions including cell-based assays for basic research through therapeutic discovery and development Principle of Eurofins DiscoverX Cell-based Assays Whether you are developing small-molecule or biologic therapeutic Explore GLP-1 Product Solutions to Support Obesity/Diabetes See GLP-1 Solutions Accelerating Obesity Therapeutics Eurofins Discovery GPCR services provides the industry's most extensive collection of validated GPCR

into industry, and his role leading and shaping multidisciplinary teams for screening and innovative therapeutics How advanced assay design is essential for translating cell-based GPCR signals to therapeutic outcomes Martin Marro leads the Cell Pharmacology group in the Diabetes, Obesity and Complications Therapeutic Marro’s career advanced through roles at Novartis and Tectonic Therapeutic, contributing to projects across key therapeutic areas—spanning metabolic, cardiovascular, and gastrointestinal diseases.

Michelle Halls reveals how organized GPCR signaling drives assay innovation and new therapeutic insights concentrations, her work highlights why receptor localization and protein complex assembly matter for therapeutic localized signaling events, how these mechanisms are hijacked in disease, and how they can be leveraged for therapeutic GPCR Premium . GPCR Podcast? Leave a Review.

therapeutic landscape of bitter taste receptors, and the importance of data-driven resources. GPCR Premium. efficacy and diagnostic innovation What the functional diversity of bitter taste receptors means for novel therapeutic GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses GPCR Podcast? Leave a Review.

Biotech founder Ajay Yekkirala shares how AI, GPCRs, and bold questions are driving next-gen pain therapeutics research career The inside story behind founding Blue Therapeutics and targeting supraspinal pain pathway Driven by the opioid crisis and the lack of non-addictive pain treatments, Ajay co-founded Blue Therapeutics GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses GPCR Podcast? Leave a Review.

Built for the GPCR community, by the GPCR community. GPCR event? Welcome. global community of GPCR scientists — all in one place. Each session explores mechanistic models, translational challenges, and real-world therapeutic implications Do I need prior knowledge of GPCR pharmacology?

Strategic approaches to building GPCR research programs that translate fundamental discoveries into clinical impact and drug development. < Back How to Build Breakthrough GPCR Programs June 4, 2026 10 AM - 11: Andrew Tobin draws from his experience leading translational GPCR programs and co-founding Keltic Pharma Intended for GPCR scientists, postdocs, and research leaders planning translational research programs As co-founder and CEO of Keltic Pharma Therapeutics, he leads a biotechnology company developing a novel

GPCR Ecosystem. Research GPCRs are one of the most important families of therapeutic targets in the pharmaceutical industry therapeutics. GPCR. accelerate the adoption of our chemical tools and foster collaborations that turn receptor biology into therapeutic

From his early work as a technician at Johns Hopkins Hospital to leading biology at Servo Therapeutics Falling in Love with GPCRs GPCR pharmacology captured his scientific curiosity. as therapeutic targets. He is passionate about mechanistic profiling of therapeutic molecules as well as drug discovery in general GPCR Podcast? Leave a Review.

GPCR webinars are live online scientific sessions focused on G protein-coupled receptor (GPCR) biology Each session explores mechanistic models, translational challenges, and real-world therapeutic implications GPCR platform. Do I need prior knowledge of GPCR pharmacology? Are these GPCR webinars free? Yes. All live GPCR webinars are free to attend. GPCR Ecosystem as a free member.

GPCR podcast. << Back to podcast list Strategic Partner(s) Signals, pH, and Discovery : Cracking GPCR Yamina underscores the therapeutic potential of GPR65, especially in the context of cancer immunotherapy , and how understanding receptor activity in acidic micro environments could unlock new therapeutic strategies GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses GPCR Podcast? Leave a Review.

I then started my career at Evotec before moving to Domain Therapeutics (called Faust pharmaceutical chemistry. 6 years ago I decided to take on a new challenge by taking the position of CSO at Confo Therapeutics Christel Menet on the web Hyphen Projects GPCRS Drug Discovery Confo Therapeutics LinkedIn Dr. GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses GPCR Podcast? Leave a Review.

build a productive, independent scientific research career in adhesion G protein-coupled receptor (aGPCR a basis for understanding aGPCR biology in the nervous system. GPCR Ecosystem Upcoming Live Expert Sessions ➚ 🔒Explore the Full Masterclass ➚ Unlock the Full Dr. GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses GPCR Podcast? Leave a Review.

He is pioneering the investigation of animal toxins acting on GPCRs, the largest therapeutic target class His strongest expertise lies in therapeutic target identification and all the steps from venom manipulations pharmacological properties of these new ligands are deemed exceptional, a lead optimization is realized and its therapeutic GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses GPCR Podcast? Leave a Review.

structures routine, the insight that seeded Heptares Therapeutics. She co-founded Heptares Therapeutics and served as Chief Scientific Officer for twelve years, through As a co-founder of Heptares Therapeutics , now called Sosei Heptares , a GPCR-focused drug discovery GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses GPCR Podcast? Leave a Review.

therapeutic target in atherosclerosis - and is candid about what happens when organizational priorities He continues to pioneer in drug discovery studying GPCRs and other target classes. His recently published book on signaling bias, Biased Signaling in Physiology, Pharmacology, and Therapeutics GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses GPCR Podcast? Leave a Review.

Discover the essence of GPCR Retreat, an international GPCR Event that empowers the GPCR field. GPCR Reatreat The GPCR Retreat focuses on advances in our understanding of how GPCRs operate in cell in the Ottawa 2017 edition, to showcase the breadth of diversity in GPCR trainee communities. We are thrilled by the overwhelming interest in this event by the GPCR research community. Sincerely, The Organizing Committee GPCR Retreat Organizers

Rosie Dawaliby "I’m an expert in early-stage drug discovery, targeting membrane proteins, especially GPCR In 2016, I joined a company that specialized in therapeutic candidate discovery targeting GPCR ( Confo Therapeutics ) as a team and project leader for antibody discovery for metabolic and inflammatory diseases GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses GPCR Podcast? Leave a Review.

I aim to discover new therapeutic approaches, and druggable molecules or refine canonical drug targets while performing various cell-based experiments to understand the binding, activation, and signaling of therapeutically relevant GPCRs. GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses GPCR Podcast? Leave a Review.

Milligan is the co-founder of both Caldan Therapeutics (2015) which discovers novel therapeutics for indications including non-alcoholic steatohepatitis (NASH) and inflammatory diseases and Keltic Pharma Therapeutics GPCR Ecosystem Upcoming Live Expert Sessions ➚ 🔒Explore the Full Masterclass ➚ Unlock the Full Dr. GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses GPCR Podcast? Leave a Review.

He has been also studying what aspects of GPCR signaling are regulated in a sex-selective manner and He received the Canadian Society of Pharmacology and Therapeutics Postdoctoral and Publication awards along with many Young Scientist Awards from the American Society for Pharmacology and Experimental Therapeutics GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses GPCR Podcast? Leave a Review.

Terry Kenakin’s unique course, Development of GPCR Ligands as Therapeutic Drugs , and gain essential signaling and drug discovery Symposium & Workshop - Brazil NEW April 1 - 3, 2025 | 2nd Peptide-Based Therapeutics Summit - USA April 2 - 3, 2025 | New therapeutic modalities: Transforming receptor pharmacology - UK Jobs NEW Open Postdoctoral position - Stanford University Structural Biologist - Confo Therapeutics Pharmacologist - Schrödinger Scientist - Biology - Superluminal Medicines Scientist I Cell Biology - Tectonic Therapeutic

<< Back to podcast list Strategic Partner(s) The Role of Quantitative Sciences in GPCRs with Dr. She has advanced the use of computational methods to meet the challenges of designing therapeutics with GPCR Upcoming Live Expert Sessions ➚ 🔒Explore the Full Masterclass ➚ Unlock the Full Dr. GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses GPCR Podcast? Leave a Review.

of GPCR science. Sep 20, 2022 — First contributor article published: Therapeutic validation of an orphan G protein‐coupled May 2022 — Media Partner at GPCR Retreat . Jul 2022 — Media Partner at GPCR ECI Transatlantic . GPCR University with the first GPCR Course led by Dr. Terry Kenakin , enrolling 30+ students . GPCR Team . May 16, 2024 — Episode #151 featured the Dr. GPCR Board .

bases for ligand binding and efficacy to help optimize the design and engineering of more efficacious therapeutics perspective in the pursuit of receptor subtype-specific ligands, a major aspect to achieve safer, on-target therapeutics The Sunahara lab has also been developing protein-based therapeutics using structure-guided design and A notable therapeutic is an enzyme that hydrolyzes cocaine. as a treatment for cocaine abuse, a debilitating disease that would require long-term and sustained therapeutic

collaborative neuroscience R&D program with Servier (France) and is the co-founder and CEO of Phrenix Therapeutics , a biotech spin-out from the Neuromedicines Discovery Centre that is developing next-generation therapeutics Prior to these roles this he was Head of Pharmacology at Heptares Therapeutics Ltd., a UK-based biotechnology These successes enabled the US$400M sale of Heptares Therapeutics Ltd. to the Sosei Group Corporation GPCR Podcast? Leave a Review.

GPCR Ecosystem. List your services and your brand on the world's first GPCR CRO Bank. Be Discoverable When GPCR Teams Are Actively Evaluating Services and Tools The GPCR CRO Bank is designed Who the GPCR CRO Bank is For? GPCR is the world's largest nonprofit community focused on GPCRs. GPCR?